iganidipine has been researched along with endothelin-1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, T; Kojima, S; Oku, H; Sugiyama, T; Watanabe, T | 1 |
| Araie, M; Fukaya, Y; Ishii, K; Matsuo, H; Sakaki, H; Tanaka, S; Waki, M | 1 |
2 other study(ies) available for iganidipine and endothelin-1
| Article | Year |
|---|---|
Improving effects of topical administration of iganidipine, a new calcium channel blocker, on the impaired visual evoked potential after endothelin-1 injection into the vitreous body of rabbits.
Topics: Administration, Topical; Analysis of Variance; Animals; Calcium Channel Blockers; Dose-Response Relationship, Drug; Endothelin-1; Evoked Potentials, Visual; Humans; Injections; Instillation, Drug; Intraocular Pressure; Piperazines; Pyridines; Rabbits; Vitreous Body | 2000 |
Iganidipine, a new water-soluble Ca2+ antagonist: ocular and periocular penetration after instillation.
Topics: Administration, Topical; Animals; Anterior Eye Segment; Autoradiography; Betaxolol; Calcium; Calcium Channel Blockers; Calcium Channels; Endothelin-1; Eye; Injections, Intravenous; Ophthalmic Solutions; Piperazines; Pyridines; Rabbits; Retina; Retinal Artery; Solubility; Vasoconstriction; Vasodilator Agents | 2003 |